Skip to main content
. 2020 Aug 6;10:1230. doi: 10.3389/fonc.2020.01230

Figure 3.

Figure 3

SHP-2 is involved in PDGF-B-induced promotion of TNBC cell proliferation and metastatic phenotype. (A) Activation of the PDGF-B/PDGFR pathway resulted in increased SHP-2 activity. (B,C) The expression of SHP-2 was significantly decreased by siSHP-2 transfection, as indicated by real-time RT-PCR (B) and western blot (C) analyses. (D) The PDGF-B-induced increase in cell growth was inhibited by knockdown of SHP-2. (E,F) The increase in BrdU incorporation (E) and PCNA expression (F) induced by PDGF-B treatment was mitigated by siSHP-2 transfection in TNBC cells. (G,H) The promoting effects of PDGF-B on cell migration (G) and invasion (H) were inhibited by SHP-2 knockdown. *Indicates P < 0.05.